Ray Dalio's MRNA Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 15,181 shares of Moderna, Inc. (MRNA) worth $447,688, representing 0.00% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in MRNA, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 605,782 shares. Largest reduction occurred in Q1 2025, reducing 605,782 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Moderna (MRNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Moderna (MRNA) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -207,029 | Reduce 93.17% | 15,181 | $29.49 |
| Q3 2025 | +222,210 | New Buy | 222,210 | $25.83 |
| Q1 2025 | -605,782 | Sold Out | 0 | $0.00 |
| Q4 2024 | +605,782 | New Buy | 605,782 | $41.58 |
| Q3 2024 | -15,309 | Sold Out | 0 | $0.00 |
| Q2 2024 | +15,309 | New Buy | 15,309 | $118.75 |
| Q3 2023 | -30,865 | Sold Out | 0 | $0.00 |
| Q2 2023 | +25,489 | Add 474.13% | 30,865 | $121.50 |
| Q1 2023 | -2,301 | Reduce 29.97% | 5,376 | $153.58 |
| Q4 2022 | -9,758 | Reduce 55.97% | 7,677 | $179.62 |
| Q3 2022 | -231,722 | Reduce 93.00% | 17,435 | $118.27 |
| Q2 2022 | +202,476 | Add 433.74% | 249,157 | $142.85 |
| Q1 2022 | +43,042 | Add 1182.80% | 46,681 | $172.25 |
| Q4 2021 | -4,670 | Reduce 56.20% | 3,639 | $253.92 |
| Q3 2021 | +8,309 | New Buy | 8,309 | $384.88 |
Ray Dalio's Moderna Investment FAQs
Ray Dalio first purchased Moderna, Inc. (MRNA) in Q3 2021, acquiring 8,309 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Moderna, Inc. (MRNA) for 15 quarters since Q3 2021.
Ray Dalio's largest addition to Moderna, Inc. (MRNA) was in Q4 2024, adding 605,782 shares worth $25.19 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 15,181 shares of Moderna, Inc. (MRNA), valued at approximately $447,688.
As of the Q4 2025 filing, Moderna, Inc. (MRNA) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Moderna, Inc. (MRNA) was 605,782 shares, as reported at the end of Q4 2024.